MENLO PARK, Calif.–(BUSINESS WIRE)—- $SMMT–Promising Data Supporting Summit’s Phase III Clinical Trials for Ivonescimab Featured at ASCO 2023.
News Ticker
- [ September 28, 2023 ] She got off dialysis. Her doctor thinks other patients with acute kidney injury can too News
- [ September 28, 2023 ] RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting News
- [ September 28, 2023 ] GSK’s ViiV to lean on long-acting HIV portfolio ahead of dolutegravir patent expiration News
- [ September 28, 2023 ] Lark Health Expands Weight Management Program to Support Guided GLP-1 Care Delivery News
- [ September 28, 2023 ] Moonshot effort aims to bioprint a human heart and implant it in pig News
Copyright © 2023 Biotech Networks, LLC
